While Eli Lilly has developed Mounjaro and Zepbound to meet the needs of people affected by diabetes and obesity, the company says it is aware of the misuse of its products, particularly for cosmetic purposes to lose weight.

The company points out that Mounjaro and Zepbound are indicated for the treatment of serious diseases; they are not approved for - and must not be used for - cosmetic weight loss.

Eli Lilly neither promotes nor encourages the use of Mounjaro, Zepbound or any other Lilly medication outside the FDA-approved indication.

Mounjaro and Zepbound should only be used on the advice of a licensed healthcare professional.

Copyright (c) 2024 CercleFinance.com. All rights reserved.